Clinical outcomes of total hip arthroplasty in patients with multiple epiphyseal dysplasia: a single centre study of eighty eight hips at a mean of sixteen year follow-up.
Chan-Woo Park, Sang-Jin Jeong, Kyungjun Cho, Min Chang Jang, Seung-Jae Lim, Youn-Soo Park
{"title":"Clinical outcomes of total hip arthroplasty in patients with multiple epiphyseal dysplasia: a single centre study of eighty eight hips at a mean of sixteen year follow-up.","authors":"Chan-Woo Park, Sang-Jin Jeong, Kyungjun Cho, Min Chang Jang, Seung-Jae Lim, Youn-Soo Park","doi":"10.1007/s00264-025-06649-3","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Multiple epiphyseal dysplasia (MED) is an inherited condition characterized by delayed and irregular ossification of the epiphyses that can lead to premature osteoarthritis. This study aimed to report the long-term outcomes of total hip arthroplasty (THA) in patients with MED.</p><p><strong>Methods: </strong>We reviewed THAs performed in MED patients at a single institution between April 1997 and May 2014. Of the 57 identified patients (103 hips), 48 (88 hips) who satisfied a minimum follow-up of tenyears were included. The Harris Hip Score was used for clinical evaluation. Hip radiographs were analyzed to evaluate changes in limb length, femoral offset, and implant stability. The mean age was 50 years and the mean follow-up duration was 16 years.</p><p><strong>Results: </strong>The mean Harris Hip Score improved from 43 preoperatively to 91 at the final evaluation (P < 0.001). Limb length and femoral offset increased after surgery by a mean of 16.1 (P < 0.001) and 7.3 mm (P < 0.001), respectively. Seven (8.0%) intraoperative periprosthetic femoral fractures were identified, but no postoperative fractures were identified. Overall, three revision surgeries were performed; two for osteolysis and one for periprosthetic joint infection. No dislocations or major neurovascular injury were observed. Implant survivorship free of any revision was 95.9% at 16 years.</p><p><strong>Conclusion: </strong>THA performed in patients with MED demonstrated excellent clinical outcomes with high implant survivorship at a mean follow-up of 16 years. Our findings suggest that THA is an effective and durable option for treating osteoarthritis secondary to MED.</p>","PeriodicalId":14450,"journal":{"name":"International Orthopaedics","volume":" ","pages":"2481-2488"},"PeriodicalIF":2.6000,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Orthopaedics","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s00264-025-06649-3","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/9/3 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"ORTHOPEDICS","Score":null,"Total":0}
引用次数: 0
Abstract
Background: Multiple epiphyseal dysplasia (MED) is an inherited condition characterized by delayed and irregular ossification of the epiphyses that can lead to premature osteoarthritis. This study aimed to report the long-term outcomes of total hip arthroplasty (THA) in patients with MED.
Methods: We reviewed THAs performed in MED patients at a single institution between April 1997 and May 2014. Of the 57 identified patients (103 hips), 48 (88 hips) who satisfied a minimum follow-up of tenyears were included. The Harris Hip Score was used for clinical evaluation. Hip radiographs were analyzed to evaluate changes in limb length, femoral offset, and implant stability. The mean age was 50 years and the mean follow-up duration was 16 years.
Results: The mean Harris Hip Score improved from 43 preoperatively to 91 at the final evaluation (P < 0.001). Limb length and femoral offset increased after surgery by a mean of 16.1 (P < 0.001) and 7.3 mm (P < 0.001), respectively. Seven (8.0%) intraoperative periprosthetic femoral fractures were identified, but no postoperative fractures were identified. Overall, three revision surgeries were performed; two for osteolysis and one for periprosthetic joint infection. No dislocations or major neurovascular injury were observed. Implant survivorship free of any revision was 95.9% at 16 years.
Conclusion: THA performed in patients with MED demonstrated excellent clinical outcomes with high implant survivorship at a mean follow-up of 16 years. Our findings suggest that THA is an effective and durable option for treating osteoarthritis secondary to MED.
期刊介绍：
International Orthopaedics, the Official Journal of the Société Internationale de Chirurgie Orthopédique et de Traumatologie (SICOT) , publishes original papers from all over the world. The articles deal with clinical orthopaedic surgery or basic research directly connected with orthopaedic surgery. International Orthopaedics will also link all the members of SICOT by means of an insert that will be concerned with SICOT matters.
Finally, it is expected that news and information regarding all aspects of orthopaedic surgery, including meetings, panels, instructional courses, etc. will be brought to the attention of the readers.
Manuscripts submitted for publication must contain a statement to the effect that all human studies have been approved by the appropriate ethics committee and have therefore been performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki. It should also be stated clearly in the text that all persons gave their informed consent prior to their inclusion in the study. Details that might disclose the identity of the subjects under study should be omitted.
Reports of animal experiments must state that the "Principles of laboratory animal care" (NIH publication No. 85-23, revised 1985) were followed, as well as specific national laws (e.g. the current version of the German Law on the Protection of Animals) where applicable.
The editors reserve the right to reject manuscripts that do not comply with the above-mentioned requirements. The author will be held responsible for false statements or for failure to fulfil the above-mentioned requirements.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
